2023
DOI: 10.1007/s10637-023-01386-z
|View full text |Cite
|
Sign up to set email alerts
|

Cytotoxicity of poly-guanidine in medulloblastoma cell lines

Abstract: SummaryMedulloblastoma (MB) is the most common pediatric brain tumor. The therapy frequently causes serious side effects, and new selective therapies are needed. MB expresses hyper sialylation, a possible target for selective therapy. The cytotoxic efficacy of a poly guanidine conjugate (GuaDex) incubated with medulloblastoma cell cultures (DAOY and MB-LU-181) was investigated. The cells were incubated with 0.05–8 µM GuaDex from 15 min to 72 h. A fluorometric cytotoxicity assay (FMCA) measured the cytotoxicity… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 50 publications
0
1
0
Order By: Relevance
“…The precise role of aberrant sialylation in MB remains elusive. One study highlighted the substantial cytotoxic efficacy of a poly-guanidine conjugate (GuaDex) in MB cell lines, noting high sialic acid expression in these cells [ 14 ]. Yet, the exact implications of hyper- or hyposialylation warrant further exploration.…”
Section: Introductionmentioning
confidence: 99%
“…The precise role of aberrant sialylation in MB remains elusive. One study highlighted the substantial cytotoxic efficacy of a poly-guanidine conjugate (GuaDex) in MB cell lines, noting high sialic acid expression in these cells [ 14 ]. Yet, the exact implications of hyper- or hyposialylation warrant further exploration.…”
Section: Introductionmentioning
confidence: 99%